Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of-mechanism in an ...

Research shows a growing link between gut microbiota and breast cancer prevention Learn how your gut health may influence breast cancer prevention ...

NBA Rank 2024 continues! See which top players just missed the top 10, and who made the biggest leaps this season.

Neuvivo, a late-clinical stage biopharmaceutical company, today announced promising results from two groundbreaking publications on its investigationa ...

In the United States, for example, immigration systems reflect and serve as the country’s official “racial” policies. This ...

A post on Instagram makes several claims against wisdom teeth removal. These claims are FALSE.Claim:In the Instagram post, ...

TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, "Titan Medical Inc.") ("Conavi" or the "Company") ...

Tech millionaire Bryan Johnson took to X, formerly Twitter, to brag about his his “liquid gold” plasma in his latest social ...

Russian astronomer Valerij Kozhevnikov has performed photometric observations of a candidate cataclysmic variable known as ...

New startups emerge from stealth; 75 companies raise $2 billion.

Neumora's lead asset, Navacaprant, shows weak efficacy in phase 2 trial. Read why we are not optimistic about NMRA's ...

Live imaging at single-vesicle resolution reveals rabphilin-3A as the first identified negative regulator of neuropeptide release in mammalian neurons.